Metraipolis › archive › dc_86365cd63a65

Advances in the Developing of SARS-CoV-2 Mpro Inhibitors — Europe PMC PPR:PPR479223

Source
Europe PMC
Original
https://europepmc.org/article/PPR/PPR479223
DOI
10.20944/preprints202204.0065.v1
License (as archived)
solo-consultazione
Archived
2026-10-08T00:15:21.278Z
SHA-256 of the archived text
487377a4a676803193c47685173c589f1257a2a85a6d6615eb0b44c4022c7796
Stable URL of this page
https://metraipolis.com/documento/dc_86365cd63a65

How to cite

Advances in the Developing of SARS-CoV-2 Mpro Inhibitors — Europe PMC PPR:PPR479223 — Europe PMC, https://europepmc.org/article/PPR/PPR479223 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_86365cd63a65 (Metraipolis archive dc_86365cd63a65, sha256 487377a4a676803193c47685173c589f1257a2a85a6d6615eb0b44c4022c7796)
BibTeX
@misc{dc86365cd63a65,
  title = {Advances in the Developing of SARS-CoV-2 Mpro Inhibitors — Europe PMC PPR:PPR479223},
  howpublished = {Europe PMC},
  url = {https://europepmc.org/article/PPR/PPR479223},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_86365cd63a65; sha256 487377a4a676803193c47685173c589f1257a2a85a6d6615eb0b44c4022c7796},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/PPR/PPR479223. Agents can read the archived copy with the MCP tool read_document.